Publications

Journal Article Epublish 4 citations
Electronic publication date
February 5, 2021

View on Pubmed.gov 33537010 | View on doi.org 10.3389/fmicb.2...

Biochemical Characterization of Arylamine acetyltransferases From .

Search for publications in this journal Front Microbiol

  • Xinning Liu

    Search for this expert
    1
  • Yuanchang Liu 2
  • Guangjian Zhao

    Search for this expert
    3
  • Yidan Zhang

    Search for this expert
    3
  • Lu Liu

    Search for this expert
    3
  • Juan Wang

    Search for this expert
    3
  • Yifan Wang

    Search for this expert
    4
  • Siyu Zhang

    Search for this expert
    5
  • Xin Li

    Search for this expert
    5
  • Dongliang Guo

    Search for this expert
    6
  • Peng Wang

    Search for this expert
    4
  • Ximing Xu

    Search for this expert
    1

Abstract

is a zoonotic bacterium that is capable of causing highly lethal diseases in humans; this pathogen is responsible for 95% of all seafood-related deaths in the United States. Arylamine -acetyltransferases (NAT, E.C. 2.3.1.5) is a major family of xenobiotic-metabolizing enzymes that can biotransform aromatic amine chemicals. In this research, to evaluate the effect of NAT on acetyl group transformation in arylamine antibiotics, we first used sequence alignment to study the structure of NAT [(VIBVN)NAT]. The gene encodes a protein of 260 amino acids, which has an approximate molecular mass of 30 kDa. Then we purified recombinant (VIBVN)NAT and determined the enzyme activity by PNPA and DTNB methods. The DTNB method indicates that this prokaryotic NAT has a particular substrate specificity towards aromatic substrates. However, (VIBVN)NAT lost most of its activity after treatment with high concentrations of urea and HO. In addition, we also explored the stability of the enzyme at different temperatures and pH values. In analyzing the influence of metal ions, the enzyme activity was significantly inhibited by Zn and Cu. The kinetic parameters and were determined using hydralazine, isoniazid, -amino salicylic acid, and -chloro--methylaniline as substrates, and the , and size distribution of (VIBVN)NAT were observed. In particular, a molecular docking study on the structure of (VIBVN)NAT was conducted to understand its biochemical traits. These results showed that (VIBVN)NAT could acetylate various aromatic amine substrates and contribute to arylamine antibiotic resistance in .

References

Am J Trop Med Hyg. 2012 Jul;87(1):153-61

FEBS Lett. 2011 Dec 15;585(24):3947-52

J Biol Chem. 1971 May 25;246(10):3250-8

Clin Pharmacol Ther. 1975 Jul;18(1):70-9

Cited by 4 citations (total)

Journal Article Research Support, Non-U.S. Gov't

Novel inhibitors of the (VIBVN) NAT protein identified through pharmacophore modeling.

Electronic publication date January 23, 2025

Search for publications in this journal Sci Rep

Wei Wei [...] Ximing Xu et al.

Arylamine N-acetyltransferases (NATs, E.C. 2.3.1.5) constitute a family of phase II drug metabolizing enzymes. These enzymes catalyze the transfer of...

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

MeSH

Specialties

Copyright

Copyright © 2021 Liu, Liu, Zhao, Zhang, Liu, Wang, Wang, Zhang, Li, Guo, Wang and Xu.